Published in Neuroendocrinology on January 01, 2001
Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology (2007) 1.22
Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer. Proc Natl Acad Sci U S A (2004) 1.20
Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol (2009) 1.14
Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats. Gut (2005) 1.00
Immunohistochemical evidence for an endocrine/paracrine role for ghrelin in the reproductive tissues of sheep. Reprod Biol Endocrinol (2005) 0.91
The roles of motilin and ghrelin in gastrointestinal motility. Int J Pept (2010) 0.88
Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88
Ghrelin improves delayed gastrointestinal transit in alloxan-induced diabetic mice. World J Gastroenterol (2008) 0.87
Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion. J Clin Diagn Res (2014) 0.86
A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice. PLoS One (2012) 0.84
In vitro selection of a peptide antagonist of growth hormone secretagogue receptor using cDNA display. Proc Natl Acad Sci U S A (2012) 0.84
The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci (2014) 0.84
New Insights in Anorexia Nervosa. Front Neurosci (2016) 0.81
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease. Neurogastroenterol Motil (2014) 0.81
Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity. Front Endocrinol (Lausanne) (2013) 0.80
Anorexia nervosa: a unified neurological perspective. Int J Med Sci (2011) 0.79
Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World J Gastroenterol (2008) 0.76
Combination of Selective Immunoassays and Mass Spectrometry to Characterize Preproghrelin-Derived Peptides in Mouse Tissues. Front Neurosci (2017) 0.75
Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science (1996) 5.55
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (1991) 5.13
Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology (2000) 2.59
Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A (1991) 2.43
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A (1995) 2.25
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science (1988) 2.24
Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics (1995) 1.96
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol (1998) 1.95
hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J (1990) 1.95
Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90
Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem (1995) 1.79
The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol (1992) 1.55
Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology (1991) 1.54
Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol (1997) 1.49
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res (1993) 1.45
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res (2001) 1.45
Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res (1990) 1.43
The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol (1993) 1.41
MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A (1997) 1.38
Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol (1992) 1.36
Imprinted gene in postnatal growth role. Nature (1998) 1.35
Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol (2002) 1.35
Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet (2001) 1.34
Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A (1992) 1.34
Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett (1995) 1.33
Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett (1997) 1.29
Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinology (1987) 1.29
pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res (1991) 1.28
Somatostatin and dementia in Parkinson's disease. Brain Res (1983) 1.25
Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol (1986) 1.24
The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J Biol Chem (2000) 1.23
Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol Med (1998) 1.23
The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol (1994) 1.23
Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res (1996) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem Soc Trans (2006) 1.20
Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest (1996) 1.19
pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology (2000) 1.18
Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. Cancer Res (1993) 1.18
Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer (1989) 1.17
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol (1997) 1.15
The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev (2011) 1.13
MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer (1997) 1.13
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem (1986) 1.11
The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta (1998) 1.11
Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab (2003) 1.11
ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release. Proc Natl Acad Sci U S A (1993) 1.11
Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene (2011) 1.10
Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary. J Comp Neurol (2001) 1.10
EMK protein kinase-null mice: dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. Dev Biol (1999) 1.10
Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene (2008) 1.08
High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res (2001) 1.08
Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J Clin Endocrinol Metab (1993) 1.07
Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis (1995) 1.07
Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology (1979) 1.04
Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett (1998) 1.04
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol (1997) 1.03
Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study. J Med Chem (1999) 1.03
Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res (1977) 1.01
Developmental expression of mouse stromelysin-3 mRNA. Development (1995) 1.01
Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides (2006) 1.01
A critical role for the glial-derived neuromodulator D-serine in the age-related deficits of cellular mechanisms of learning and memory. Aging Cell (2006) 1.00
Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol Endocrinol (1989) 1.00
Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer (1995) 0.99
A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Res (1995) 0.99
Age-related alterations of GABAergic input to CA1 pyramidal neurons and its control by nicotinic acetylcholine receptors in rat hippocampus. Neuroscience (2006) 0.98
Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells. Cancer Treat Res (1988) 0.97
Pulsatile cerebrospinal fluid and plasma ghrelin in relation to growth hormone secretion and food intake in the sheep. J Neuroendocrinol (2008) 0.96
Two new peptides to improve post-operative gastric ileus in dog. Peptides (2003) 0.95
Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer (1991) 0.95
Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut (2004) 0.94
Motherhood-induced memory improvement persists across lifespan in rats but is abolished by a gestational stress. Eur J Neurosci (2006) 0.94
Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology (2005) 0.94
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J Biol Chem (1995) 0.94
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. Arterioscler Thromb Vasc Biol (1999) 0.94
Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. J Mol Biol (2001) 0.92
Contribution of the d-Serine-Dependent Pathway to the Cellular Mechanisms Underlying Cognitive Aging. Front Aging Neurosci (2010) 0.92
Intrahypothalamic growth hormone feedback: from dwarfism to acromegaly in the rat. Endocrinology (1997) 0.92
Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest (1992) 0.92